Literature DB >> 26484788

Beta-blockers in the treatment of catecholaminergic polymorphic ventricular tachycardia.

Christian van der Werf1, Krystien V Lieve2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26484788     DOI： 10.1016/j.hrthm.2015.10.027

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  3 in total

1.  In Vivo Ryr2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia.

Authors:  Xiaolu Pan; Leonne Philippen; Satadru K Lahiri; Ciaran Lee; So Hyun Park; Tarah A Word; Na Li; Kelsey E Jarrett; Rajat Gupta; Julia O Reynolds; Jean Lin; Gang Bao; William R Lagor; Xander H T Wehrens
Journal:  Circ Res       Date:  2018-09-28       Impact factor: 17.367

2.  Safety and efficacy of flecainide for patients with catecholaminergic polymorphic ventricular tachycardia: A systematic review and meta-analysis.

Authors:  Guangqiang Wang; Na Zhao; Shu Zhong; Yingrong Wang; Jianping Li
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 3.  Mechanisms underlying pathological Ca2+ handling in diseases of the heart.

Authors:  Satadru K Lahiri; Yuriana Aguilar-Sanchez; Xander H T Wehrens
Journal:  Pflugers Arch       Date:  2021-01-05       Impact factor: 3.657
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.